ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1849	National Cancer Institute	Html	es	Tratamiento del cáncer de próstata (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de próstata.	Compton CC 0.32822 preoperative nomogram 0.351745 outcome after 0.326979 progression after psa 0.331315 Albertsen PC 0.319652 prostate specific 0.36016 clinically localized 0.351298 Kabalin JN 0.319448 American Cancer Society 0.354812 Radical prostatectomy versus 0.362604 Eastham JA 0.338512 versus watchful waiting 0.321163 following radical prostatectomy 0.340792 PSA anormal 0.32618 7th ed 0.328183 Radiat Oncol Biol 0.401027 Estados Unidos 0.34545 Natl Cancer Inst 0.962766 cancer staging 0.41957 men with 0.323828 Stamey TA 0.333393 Radical prostatectomy treated 0.32026 Union Against Cancer 0.327902 versus gleason 0.324714 prostate biopsy 0.325976	with psa testing 0.327026 ecografía transrectal 0.331137 prostate with radiotherapy 0.319235 Cancer Facts 0.330577 gammagrafía ósea 0.32132 radical prostatectomy 0.783813 after radical prostatectomy 0.482799 Cancer Staging Manual 0.40851 recurrence after 0.340439 New York 0.323092 Clin Oncol 0.387513 predict pathological stage 0.323561 Oncol Biol Phys 0.404255 Oncology Consensus Panel 0.323099 Kattan MW 0.336259 systematic review 0.320343 with clinically localized 0.323887 Byrd DR 0.326227 American Joint Committee 0.318729 Partin AW 0.341859 transrectal ultrasound guided 0.325554 AJCC Cancer Staging 0.413497 Edge SB 0.328269 PSA following 0.325762	CLICK HERE
1885	National Cancer Institute	Html	es	Tratamiento de los cánceres poco comunes en la niñez (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los cánceres poco comunes en la niñez como los cánceres de la cabeza y el cuello, el tórax, el abdomen, el aparato reproductor, la piel y otros.	Group Childhood Cancer 0.303634 Kadish Estadio Descripción 0.300271 cancer statistics 0.326488 pediatric rare tumors 0.992234 patients with relapsed 0.372754 cuadro clínico 0.354432 Advanced Solid Tumors 0.370423 estadificación posoperatoria 0.711901 GPOH Pediatric Rare 0.343984 cooperative study group 0.363939 Sin embargo 0.560837 ATA Task Force 0.473736 Pediatric Patients with 0.461297 Childhood Cancer Research 0.442875 cuáles pacientes 0.308117 Targeted Therapy Directed 0.368386 Treating Pediatric Patients 0.460472 or histiocytic disorders 0.361605 Internet ClinicalTrials.gov 0.45578 metástasis distantes 0.307395 Children's Oncology Group 0.570172 niños vs 0.418573 International Classification 0.392171 or refractory advanced 0.367754 tiroides medular nem2 0.365237	very rare tumors 0.299588 Refractory Advanced Solid 0.36854 carcinoma nasofaríngeo 0.834137 Pediatric Molecular Analysis 0.447293 Pediatric MATCH 0.923242 pediatric thyroid cancer 0.456559 End Results 0.382399 gammagrafía ósea 0.326636 BRAF V600E 0.354329 Childhood Cancer 0.803535 relapsed or refractory 0.373353 efectos tardíos 0.368787 ATA Pediatric Risk 0.307191 menudo metástasis 0.316315 Riesgo pediátrico intermedio 0.363674 rare pediatric tumors 0.355894 PDQ Tratamiento 0.348659 mutaciones braf v600e 0.349145 NCI-COG Pediatric Molecular 0.449773 gammagrafía diagnóstica 0.608069 Clin Oncol 0.421865 subgrupo xi 0.374046 with relapsed or 0.368469 european cooperative study 0.370036	CLICK HERE
1939	National Cancer Institute	Html	es	Adaptación al cáncer: ansiedad y sufrimiento (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las difíciles respuestas emocionales que se presentan en muchos de los pacientes con cáncer. Este sumario se enfoca en asuntos de la adaptación normal, alteración psicosocial y trastornos de adaptación.	La espiritualidad 0.829227 siguientes aspectos 0.951689 intensa ansiedad 0.886965 siguientes tipos 0.835996 largo plazo 0.911949 ¿Qué efectos 0.840354 siguientes períodos 0.85698 siguientes síntomas 0.824791 siguientes riesgos 0.776419 Visuals Online 0.784027 Physician Data 0.774429 siguientes problemas 0.817253	siguientes factores 0.894404 Mucha transpiración 0.807275 resultados correctos 0.846693 libre uso 0.789 siguientes situaciones 0.941031 Data Query 0.774207 siguientes características 0.904197 Cancer Institute 0.786402 página manejo 0.784108 suficiente dinero 0.80221 siguientes sumarios 0.945414 usa compulsiones 0.805006	CLICK HERE
2013	National Cancer Institute	Html	es	Aspectos generales de los exámenes de detección del cáncer (PDQ®)–Versión para pacientes	Información sobre la medición de la eficacia de los exámenes de detección del cáncer y la evaluación de la solidez de las pruebas obtenidas en estudios de investigación de detección del cáncer.	suficiente información 0.640426 riesgos.Algunos exámenes 0.948845 posibles factores 0.658466 End Results 0.782283 siguientes aspectos 0.657281 cabo ensayos 0.656668 ¿Los exámenes 0.83489 siguientes tipos 0.726625 efecto secundario adverso 0.681584 cuánto tiempo 0.658052 grupo pacientes 0.645515 información ayuda 0.635388 National Cancer Institute 0.643177	siguientes riesgos 0.629124 Instituto Nacional 0.984309 antecedentes familiares 0.663533 suficientes pruebas 0.65243 Physician Data Query 0.768953 Estados Unidos 0.927922 menor tiempo 0.639093 única razón 0.651582 posibles beneficios 0.675509 determinada enfermedad 0.640319 cuáles pruebas 0.82218 términos riesgo 0.746808 PDQ Aspectos 0.65214	CLICK HERE
2055	National Cancer Institute	Html	es	Obesidad y cáncer	Hoja informativa que resume la evidencia que relaciona el sobrepeso y la obesidad al riesgo de cáncer.	body mass 0.350143 Cancer Research Fund 0.305964 Wang F 0.302675 IMC Categoría 0.303709 ligero aumento 0.313291 anthropometric factors 0.304184 pooled analysis from 0.302634 Wang X 0.302352 observational studies 0.307777 male breast 0.30286 risk factors 0.317009 Kitahara CM 0.305306 to modifiable factors 0.302578 ovarian cancer 0.313319 Estados Unidos 0.306361 mechanisms linking obesity 0.302489 PubMed Abstract 0.981157 Women's Health Initiative 0.305794 obesity prevalence among 0.302851 endometrial cancer 0.302426 Clinical Oncology 0.31976 obesidad causa 0.307215 prospective observational studies 0.307481 International Journal 0.314669 gallbladder cancer 0.310353	body size throughout 0.303222 United States 0.304211 Renehan AG 0.302352 Body Fatness 0.302339 mayores riesgos 0.303903 hormonal risk factors 0.304977 dose-response meta-analysis 0.303474 Cancer Research 0.314608 PLoS Medicine 0.303294 epidemiological studies 0.304197 Cancer Prevention Trial 0.306279 Current Oncology Reports 0.302446 different risk factors 0.304931 systematic review 0.305695 Annual Review 0.302768 risk according 0.303418 Excess body weight 0.303071 physical activity 0.302433 pooled analysis 0.316054 Cancer Institute 0.315531 lymphedema risk factors 0.304822 JAMA Oncology 0.304192 prospective studies 0.331726 New England Journal 0.306423	CLICK HERE
15480	National Cancer Institute	Html	en	Grantees or Grant Applicants Submitting Data	In order to be compliant with the Genomic Data Sharing (GDS) Policy, extramural investigators should use the following to guide their steps through the grant life-cycle process.	annual Progress Report 0.62504 data 0.849889 Institutional Certification 0.882661 similar manner 0.478201 accession number 0.48592 section 0.333306 PO/PD 0.491096 Assignment 0.33161 approved DSP 0.538409 extramural investigators 0.782153 1. Plan Project 0.689974 Basic Study Information 0.674507 grant funding 0.568662 confirmation 0.333875 steps 0.331094 ARA 0.342301 submission portal 0.610861 plans 0.336284 grant application 0.941037 receipt 0.33802 GDS policy 0.525866 Upload Data 0.545134 dbGaP staff 0.485771 data certification process 0.735794 program officer/program director 0.674634	grants process 0.480049 grant life-cycle process 0.816123 Basic Information form 0.63633 dbGaP Study Release 0.648367 DSPs 0.34954 initiation 0.332734 pre-award process 0.509608 submission process 0.502601 required fields 0.479311 expectations 0.381962 place 0.332574 3. 0.332387 cleaning 0.332176 data submission formats 0.780089 study submission information 0.687432 Resource Sharing Plan 0.663305 QA/QC Data Submission 0.730259 Information form 0.651102 Submit Just-in-Time Materials 0.722172 Data Generation Completed 0.715899 GPA 0.642745 quality assurance check 0.641113 Write Grant Application 0.78666 data upload 0.531576	CLICK HERE
16696	National Cancer Institute	Html	en	Understanding Cervical Changes: A Health Guide for Women	Explains abnormal Pap test, HPV test, and Pap/HPV cotest results. Treatment and follow-up care for abnormal cervical cancer screening results including ASC-US, AGC, LSIL, ASC-H, HSIL, AIS. Learn about colposcopy, types of biopsies, CIN, and HPV vaccine.	cervical screening test 0.296143 cervical cancer cells 0.337703 health care provider 0.931179 cause cervical cancer 0.303315 abnormal cervical changes 0.298611 HPV types 0.331542 hpv infections 0.33479 abnormal cervical cell 0.295805 different HPV test 0.298266 cervical screening tests 0.300727 cervical cells 0.440061 HPV test work 0.298659 test results 0.460749 abnormal cervical screening 0.340129 HPV test 0.548179 cervical cancer screening 0.419584 HPV test result 0.334901 pap test 0.669223 cervical cancer 0.659605 abnormal test result 0.292044 high-risk hpv types 0.317446 HPV test results 0.312992 high-risk HPV infection 0.300301 women 0.2963	treatment 0.297209 abnormal cervical cells 0.352195 HPV vaccination 0.281435 Follow-Up Testing section 0.335149 HPV vaccine 0.303379 routine HPV testing 0.291048 HPV 0.555747 Pap test result 0.316098 Low-risk HPV types 0.299422 cervical cell changes 0.36625 Cervical screening recommendations 0.28727 abnormal pap test 0.394575 abnormal cervical cancer 0.33209 HPV vaccine series 0.282155 Normal Pap test 0.282878 Unsatisfactory Pap test 0.281328 Possible next steps 0.307487 common abnormal Pap 0.287706 HPV tests 0.293108 pap test results 0.389844 HPV infection 0.355986 abnormal cervical tissue 0.293862 recent abnormal Pap 0.289466 Cervical Cancer Treatment 0.291973	CLICK HERE
16713	National Cancer Institute	Html	es	Iniciativa de Respuestas Excepcionales: Preguntas y respuestas	El Instituto Nacional del Cáncer (NCI) emprendió la Iniciativa de Respuestas Excepcionales a fin de entender la base molecular de los tumores en pacientes de cáncer que responden en forma excepcional al tratamiento, principalmente quimioterapia.	Exceptional Responders 0.786989 suficiente información 0.61563 Sequencing Identifies 0.586522 poderosa técnica 0.577603 tejido no puede usarse para otras 0.723672 siguientes criterios 0.611344 llamado data access request 0.624892 ARN mensajero 0.581431 Everolimus Sensitivity 0.593577 suficiente ácido 0.633822 Genome Sequencing 0.743091 suficiente tejido 0.888254 genes tsc1 0.601267 datos dbGAP 0.580415 estudio piloto 0.664379 tejido fijo en formol 0.691726 Exceptional Responders Data 0.636284	Exceptional Responders Initiative 0.702067 consentimiento apropiado para investigaciones 0.678722 fármacos similares. El estudio 0.741131 Instituto Nacional 0.57833 gen tsc1 0.738554 Trials Support Unit 0.638511 descubrimientos prometedores 0.585883 datos clínicos a medidata 0.649717 Revisión Central de Adultos 0.624848 extensa experiencia 0.580712 requiere varios pasos 0.583341 pacientes con respuestas 0.618767 centro biospecimen core 0.880872 tumores sólidos 0.758056 enfermedad y el 0.583796 aun pacientes 0.751408	CLICK HERE
17222	National Cancer Institute	Html	en	Tumor DNA Sequencing in Cancer Treatment	Tumor DNA sequencing (also called genetic profiling or genetic testing) is a test to identify DNA changes in a patient’s cancer. In some cases, this information can help determine a treatment plan.	unique DNA changes 0.327494 health care provider 0.21495 lung tumor 0.253938 tumor sequencing 0.343527 specific genetic alterations 0.302101 healthy cells 0.230873 Multigene panel tests 0.208409 health care team 0.2107 frequently used sequencing 0.320207 hereditary cancer syndromes 0.221971 health care providers 0.211937 whole-genome sequencing 0.314537 cancer types 0.228448 DNA changes 0.331071 patient care 0.205253 targeted sequencing tests 0.342426 broad tumor DNA 0.375946 heterogeneous tumor 0.233471 DNA sequencing tests 0.507176 precision medicine 0.222532 single cancer type 0.228039 lung cancer cells 0.3596 treatment 0.286045 precision medicine trials 0.205063	DNA alteration 0.251455 NCI-COG Pediatric MATCH 0.207207 inherited genetic alteration 0.228682 DNA sequence 0.253453 cancer cells 0.454035 unique genetic alterations 0.280668 sequencing tests cost 0.308627 EGFR mutation 0.209321 Broad DNA sequencing 0.411749 cancer-causing DNA changes 0.297683 way cells function 0.250384 tumor dna 0.91525 tumor dna sequencing 0.748819 DNA sequencer 0.254089 Clinical tumor DNA 0.406068 health care 0.275099 DNA sequencing test 0.405098 mRNA expression test 0.209986 breast cancer 0.203535 genetic alterations 0.703142 cancer 0.512553 standard treatment 0.204466 whole-exome sequencing 0.314247 quantitative mRNA test 0.208612	CLICK HERE
17287	National Cancer Institute	Html	es	Búsqueda de servicios médicos	Sugerencias para elegir a un doctor o un establecimiento de tratamiento, opciones de cuidados médicos, atención a domicilio y cuidados para pacientes terminales.	teléfono al ACoS 0.406963 practicantes miembros 0.405783 línea quality check 0.40869 es el doctor 0.42878 Asociación Estadounidense 0.423296 usa rayos 0.406918 cirujanos miembros 0.406162 cuenta los costos 0.406987 capacitación de residencia 0.407585 Atención Médica Asequible 0.412098 Especialistas Médicos 0.407972 la asociación médica estadounidense 0.414538 información sobre cobertura 0.405498 International Cancer Control 0.40739	Colegio Estadounidense 0.438106 seguro médico 0.61246 Seguros Médicos 0.413052 Oncología Clínica 0.406552 pagar el tratamiento 0.41398 paciente satisface los requisitos 0.408803 Comisión Conjunta 0.429316 Oncólogo radiólogo 0.407999 los estados unidos 0.40683 atención médica 0.448896 Estados Unidos 0.919617 información a disposición 0.40585 cuestiones de viaje 0.405374	CLICK HERE